These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24505852)

  • 1. Bringing smart pills to market: FDA regulation of ingestible drug/device combination products.
    Avery M; Liu D
    Food Drug Law J; 2011; 66(3):329-52, i. PubMed ID: 24505852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from innovation in drug-device combination products.
    Couto DS; Perez-Breva L; Saraiva P; Cooney CL
    Adv Drug Deliv Rev; 2012 Jan; 64(1):69-77. PubMed ID: 22200650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-device combination products: regulatory landscape and market growth.
    Bayarri L
    Drugs Today (Barc); 2015 Aug; 51(8):505-13. PubMed ID: 26380388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oversight overhaul: eliminating the premarket review of medical devices and implementing a provider-centered postmarket surveillance strategy.
    Scott B
    Food Drug Law J; 2011; 66(3):377-404, ii. PubMed ID: 24505854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and Device Development: Tips for Optimizing Your Experience With the Food and Drug Administration.
    Brooks SS
    Tech Vasc Interv Radiol; 2017 Jun; 20(2):109-115. PubMed ID: 28673647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination products: modernizing the regulatory paradigm.
    Hunter NL; Sherman RE
    Nat Rev Drug Discov; 2017 Aug; 16(8):513-514. PubMed ID: 28496147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new FDA combination products programme.
    Donawa M
    Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The road to market implantable drug delivery systems: a review on US FDA's regulatory framework and quality control requirements.
    Al-Jawadi S; Capasso P; Sharma M
    Pharm Dev Technol; 2018 Dec; 23(10):953-963. PubMed ID: 30084277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA weighs policing electronic patient record.
    Hosp Case Manag; 1997 May; 5(5):81-3. PubMed ID: 10167258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drug device combination products: Regulatory and scientific considerations.
    Choi SH; Wang Y; Conti DS; Raney SG; Delvadia R; Leboeuf AA; Witzmann K
    Int J Pharm; 2018 Jun; 544(2):443-454. PubMed ID: 29170118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RU-486: legal and policy issues confronting the Food and Drug Administration.
    Muhl C
    J Leg Med; 1993 Jun; 14(2):319-47. PubMed ID: 8340714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of medical devices in radiology: current standards and future opportunities.
    Smith JJ
    Radiology; 2001 Feb; 218(2):329-35. PubMed ID: 11161144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA & digital mammography: why has FDA required full field digital mammography systems to be regulated as potentially dangerous devices for more than 10 years?
    Nields MW
    Acad Radiol; 2010 May; 17(5):652-7. PubMed ID: 20380981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; physical medicine devices; classification of the nonpowered lower extremity pressure wrap. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Jul; 79(128):37948-50. PubMed ID: 25016621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: FDA oversight.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.